|
|
||||||||
Radiopharmaceuticals Department, Soreq Nuclear Research Center, Yavne 70600
Division of Nuclear Medicine, Beilinson Hospital, Sackler School of Medicine, Tel-Aviv University, Petah Tiqwe, Israel
Correspondence: For reprints contact: David Issachar, PhD, Radiopharmaceuticals Dept., Soreq Nuclear Research Center, Yavne 70600, Israel.
ABSTRACT
A new separation system for an 191Os/191mIr generator is described. The system is composed of two columns in a series: a main column, packed with silica gel impregnated with tridodecylmethylammonium chloride (loaded with high activity 191Os as an osmyl chloride); and a scavenger column, packed with activated charcoal. Iridium-191m is eluted from the generator by pH 1 saline. For clinical use the eluate is buffered by succinate solution before injection. This new system is characterized by high performance (
25% 191mIr recovery with 5 x 104% 191Os breakthrough) and long shelf-life (3 wk). The buffered eluate is sterile, pyrogen-free, and nontoxic, and contains no 192Ir. It is suitable for first-pass radionuclide angiocardiography with a very low radiation dose to the patient.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |